Biomedical Journal最新文献

筛选
英文 中文
Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice. Hirsutella sinensis 多糖和 Parabacteroides goldsteinii 可减轻咪喹莫特治疗小鼠狼疮的严重程度。
IF 4.1 3区 医学
Biomedical Journal Pub Date : 2024-06-18 DOI: 10.1016/j.bj.2024.100754
Shih-Hsin Chang, Yun-Fei Ko, Jian-Ching Liau, Cheng-Yeu Wu, Tsong-Long Hwang, David M Ojcius, John D Young, Jan Martel
{"title":"Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice.","authors":"Shih-Hsin Chang, Yun-Fei Ko, Jian-Ching Liau, Cheng-Yeu Wu, Tsong-Long Hwang, David M Ojcius, John D Young, Jan Martel","doi":"10.1016/j.bj.2024.100754","DOIUrl":"https://doi.org/10.1016/j.bj.2024.100754","url":null,"abstract":"<p><strong>Background: </strong>The incidence of autoimmune diseases is increasing in developed countries, possibly due to the modern Western diet and lifestyle. We showed earlier that polysaccharides derived from the medicinal fungus Hirsutella sinensis produced anti-inflammatory, anti-diabetic and anti-obesity effects by modulating the gut microbiota and increasing the abundance of the commensal Parabacteroides goldsteinii in mice fed with a high-fat diet.</p><p><strong>Methods: </strong>We examined the effects of the prebiotics, H. sinensis polysaccharides, and probiotic, P. goldsteinii, in a mouse model of imiquimod-induced systemic lupus erythematosus.</p><p><strong>Results: </strong>The fungal polysaccharides and P. goldsteinii reduced markers of lupus severity, including the increase of spleen weight, proteinuria, and serum levels of anti-DNA auto-antibodies and signal transducer and activator of transcription 4 (STAT4). Moreover, the polysaccharides and P. goldsteinii improved markers of kidney and liver functions such as creatinine, blood urea nitrogen, glomerulus damage and fibrosis, and serum liver enzymes. However, the prebiotics and probiotics did not influence gut microbiota composition, colonic histology, or expression of tight junction proteins in colon tissues.</p><p><strong>Conclusions: </strong>Our results indicate that H. sinensis polysaccharides and the probiotic P. goldsteinii can reduce lupus markers in imiquimod-treated mice. These prebiotics and probiotics may therefore be added to other interventions conducive of a healthy lifestyle in order to counter autoimmune diseases.</p>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":" ","pages":"100754"},"PeriodicalIF":4.1,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel artificial tricalcium phosphate and magnesium composite graft facilitates angiogenesis in bone healing. 新型人工磷酸三钙和镁复合移植物可促进骨愈合过程中的血管生成。
IF 5.5 3区 医学
Biomedical Journal Pub Date : 2024-06-03 DOI: 10.1016/j.bj.2024.100750
Yuan-Hsin Tsai, Chun-Chieh Tseng, Yun-Chan Lin, Howida M Nail, Kuan-Yu Chiu, Yen-Hao Chang, Ming-Wei Chang, Feng-Huei Lin, Hui-Min David Wang
{"title":"Novel artificial tricalcium phosphate and magnesium composite graft facilitates angiogenesis in bone healing.","authors":"Yuan-Hsin Tsai, Chun-Chieh Tseng, Yun-Chan Lin, Howida M Nail, Kuan-Yu Chiu, Yen-Hao Chang, Ming-Wei Chang, Feng-Huei Lin, Hui-Min David Wang","doi":"10.1016/j.bj.2024.100750","DOIUrl":"https://doi.org/10.1016/j.bj.2024.100750","url":null,"abstract":"<p><strong>Background: </strong>Bone grafting is the standard treatment for critical bone defects, but autologous grafts have limitations like donor site morbidity and limited availability, while commercial artificial grafts may have poor integration with surrounding bone tissue, leading to delayed healing. Magnesium deficiency negatively impacts angiogenesis and bone repair. Therefore, incorporating magnesium into a synthetic biomaterial could provide an excellent bone substitute. This study aims to evaluate the morphological, mechanical, and biological properties of a calcium phosphate cement (CPC) sponge composed of tetracalcium phosphate (TTCP) and monocalcium phosphate monohydrate (MCPM), which could serve as an excellent bone substitute by incorporating magnesium.</p><p><strong>Methods: </strong>This study aims to develop biomedical materials composed mainly of TTCP and MCPM powder, magnesium powder, and collagen. The materials were prepared using a wet-stirred mill and freeze-dryer methods. The particle size, composition, and microstructure of the materials were investigated. Finally, the biological properties of these materials, including 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay for biocompatibility, effects on bone cell differentiation by alkaline phosphatase (ALP) activity assay and tartrate-resistant acid phosphatase (TRAP) activity assay, and endothelial cell tube formation assay for angiogenesis, were evaluated as well.</p><p><strong>Results: </strong>The data showed that the sub-micron CPC powder, composed of TTCP/MCPM in a 3.5:1 ratio, had a setting time shorter than 15 minutes and a compressive strength of 4.39±0.96 MPa. This reveals that the sub-micron CPC powder had an adequate setting time and mechanical strength. We found that the sub-micron CPC sponge containing magnesium had better biocompatibility, including increased proliferation and osteogenic induction effects without cytotoxicity. The CPC sponge containing magnesium also promoted angiogenesis.</p><p><strong>Conclusion: </strong>In summary, we introduced a novel CPC sponge, which had a similar property to human bone promoted the biological functions of bone cells, and could serve as a promising material used in bone regeneration for critical bone defects.</p>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":" ","pages":"100750"},"PeriodicalIF":5.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141260452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression 长非编码 RNA TUG1 通过增强 ZBTB7C 的表达促进骨肉瘤的恶性发展
IF 5.5 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100651
Xueying An , Wenshu Wu , Pu Wang , Abdurahman Mahmut , Junxia Guo , Jian Dong , Wang Gong , Bin Liu , Lin Yang , Yuze Ma , Xingquan Xu , Jianmei Chen , Wangsen Cao , Qing Jiang
{"title":"Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression","authors":"Xueying An ,&nbsp;Wenshu Wu ,&nbsp;Pu Wang ,&nbsp;Abdurahman Mahmut ,&nbsp;Junxia Guo ,&nbsp;Jian Dong ,&nbsp;Wang Gong ,&nbsp;Bin Liu ,&nbsp;Lin Yang ,&nbsp;Yuze Ma ,&nbsp;Xingquan Xu ,&nbsp;Jianmei Chen ,&nbsp;Wangsen Cao ,&nbsp;Qing Jiang","doi":"10.1016/j.bj.2023.100651","DOIUrl":"10.1016/j.bj.2023.100651","url":null,"abstract":"<div><h3>Background</h3><p>Dysregulation of long non-coding RNAs (lncRNAs) is an important component of tumorigenesis. Aberrant expression of lncRNA taurine upregulated gene 1 (lncTUG1) has been reported in various tumors; however, its precise role and key targets critically involved in osteosarcoma (OS) progression remain unclear.</p></div><div><h3>Methods</h3><p>The expression profiles of lncRNAs and their regulated miRNAs related to OS progression were assessed by bioinformatics analysis and confirmed by qRT-PCR of OS cells. The miRNA targets were identified by transcriptome sequencing and verified by luciferase reporter and RNA pull-down assays. Several <em>in vivo</em> and <em>in vitro</em> approaches, including CCK8 assay, western blot, qRT-PCR, lentiviral transduction and OS cell xenograft mouse model were established to validate the effects of lncTUG1 regulation of miRNA and the downstream target genes on OS cell growth, apoptosis and progression.</p></div><div><h3>Results</h3><p>We found that lncTUG1 and miR-26a-5p were inversely up or down-regulated in OS cells, and siRNA-mediated lncTUG1 knockdown reversed the miR-26a-5p down-regulation and suppressed proliferation and enhanced apoptosis of OS cells. Further, we identified that an oncoprotein ZBTB7C was also upregulated in OS cells that were subjected to lncTUG1/miR-26a-5p regulation. More importantly, ZBTB7C knockdown reduced the ZBTB7C upregulation and ZBTB7C overexpression diminished the anti-OS effects of lncTUG1 knockdown in the OS xenograft model.</p></div><div><h3>Conclusions</h3><p>Our data suggest that lncTUG1 acts as a miR-26a-5p sponge and promotes OS progression <em>via</em> up-regulating ZBTB7C, and targeting lncTUG1 might be an effective strategy to treat OS.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100651"},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000884/pdfft?md5=3064c0fef20489eefc4debd0e794f500&pid=1-s2.0-S2319417023000884-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9974615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes 获得性免疫缺陷综合症与 SARS-CoV-2 N 基因型的相关性。
IF 4.1 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100650
{"title":"Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes","authors":"","doi":"10.1016/j.bj.2023.100650","DOIUrl":"10.1016/j.bj.2023.100650","url":null,"abstract":"<div><h3>Background</h3><p>Epigenetics and clinical observations referring to Betacoronavirus lead to the conjecture that Sarbecovirus may have the ability to infect lymphocytes using a different way than the spike protein. In addition to inducing the death of lymphocytes, thus drastically reducing their population and causing a serious immune deficiency, allows it to remain hidden for long periods of latency using them as a viral reservoir in what is named Long-Covid Disease. Exploring possibilities, the hypothesis is focused on that N protein may be the key of infecting lymphocytes.</p></div><div><h3>Method</h3><p>The present article exhibits a computational assay for the latest complete sequences reported to GISAID, correlating N genotypes with an enhancement in the affinity of the complex that causes immune deficiency in order to determine a good docking with the N protein and some receptors in lymphocytes.</p></div><div><h3>Results</h3><p>A novel high-interaction coupling of N-RBD and CD147 is presented as the main way of infecting lymphocytes, allowing to define those genotypes involved in their affinity enhancement.</p></div><div><h3>Conclusion</h3><p>The hypothesis is consistent with the mutagenic deriving observed on the in-silico assay, which reveals that genotypes N/120 and N/152 are determinant to reduce the Immune Response of the host infecting lymphocytes, allowing the virus persists indefinitely and causing an Acquire Immune Deficiency Syndrome.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100650"},"PeriodicalIF":4.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000872/pdfft?md5=1edaaac170d38d8c21d14f03478af8b3&pid=1-s2.0-S2319417023000872-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10030002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut mycobiome in metabolic diseases: Mechanisms and clinical implication 代谢性疾病中的肠道霉菌生物群:机制和临床意义。
IF 4.1 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100625
{"title":"Gut mycobiome in metabolic diseases: Mechanisms and clinical implication","authors":"","doi":"10.1016/j.bj.2023.100625","DOIUrl":"10.1016/j.bj.2023.100625","url":null,"abstract":"<div><p>Obesity, type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are three common metabolic diseases with high prevalence worldwide. Emerging evidence suggests that gut dysbiosis may influence the development of metabolic diseases, in which gut fungal microbiome (mycobiome) is actively involved. In this review, we summarize the studies exploring the composition changes of gut mycobiome in metabolic diseases and mechanisms by which fungi affect the development of metabolic diseases. The current mycobiome-based therapies, including probiotic fungi, fungal products, anti-fungal agents and fecal microbiota transplantation (FMT), and their implication in treating metabolic diseases are discussed. We highlight the unique role of gut mycobiome in metabolic diseases, providing perspectives for future research on gut mycobiome in metabolic diseases.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100625"},"PeriodicalIF":4.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000628/pdfft?md5=afebb46db7828c38f6f0185daf91db90&pid=1-s2.0-S2319417023000628-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10045400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing transvenous coiling and transarterial embolization with Onyx/NBCA for cavernous sinus dural arteriovenous fistulas: A retrospective study in a single center 海绵窦硬脑膜动静脉瘘的经静脉套扎术和经动脉栓塞术与 Onyx/NBCA 的比较:单个中心的回顾性研究
IF 5.5 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100657
Yi-Ming Wu , Chuan-Min Lin , Sachin Giri , Yao-liang Chen , Chien-Hung Chang , Ho-Fai Wong
{"title":"Comparing transvenous coiling and transarterial embolization with Onyx/NBCA for cavernous sinus dural arteriovenous fistulas: A retrospective study in a single center","authors":"Yi-Ming Wu ,&nbsp;Chuan-Min Lin ,&nbsp;Sachin Giri ,&nbsp;Yao-liang Chen ,&nbsp;Chien-Hung Chang ,&nbsp;Ho-Fai Wong","doi":"10.1016/j.bj.2023.100657","DOIUrl":"10.1016/j.bj.2023.100657","url":null,"abstract":"<div><h3>Background</h3><p>Endovascular management is the gold standard for cavernous sinus dural arteriovenous fistulas (CS-dAVFs) in patients with signs of ophthalmoplegia, visual defects, or intolerable clinical symptoms. Although the efficacy of embolization has been confirmed, complications during post-endovascular management have not been compared in a more extensive CS-dAVFs case series. Therefore, we compared the effectiveness and peri-procedural complications of transvenous coiling with those of transarterial embolization (TAE) using liquid embolic agents.</p></div><div><h3>Methods</h3><p>We reviewed 71 patients with CS-dAVFs in one medical center from 2005/7 to 2016/7. We performed seventy-seven procedures on 71 patients, including six recurrent cases. We compared the efficacy and peri-procedural complications of transvenous coiling and TAE.</p></div><div><h3>Results</h3><p>The complete occlusion rate for transvenous coiling was 79.2%, and that for TAE was 75.0%. Findings revealed (1) similar ophthalmoplegia complication rates (<em>p</em> = 0.744); (2) more frequent and permanent CN5 or CN7 neuropathy with liquid embolic agent use (<em>p</em> = 0.031 and 0.028, respectively); and (3) a higher risk of infarction or ICH (<em>p</em> = 0.002 and 0.028, respectively) in response to aggressive TAE.</p></div><div><h3>Conclusion</h3><p>Transvenous cavernous sinus coiling resulted in a similar occlusion rate and lower complication risk than transarterial Onyx/n-butyl cyanoacrylate (NBCA). We can access via an occluded inferior petrosal sinus (even contralateral), and direct transorbital puncture was a safe alternative. TAE with Onyx/NBCA was helpful in cases of oligo-feeders, but multidisciplinary treatment and multi-session TAE were usually needed for patients with multiple feeders and complex fistulas.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100657"},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S231941702300094X/pdfft?md5=2c2370b7a56affdc671763cd91b96b25&pid=1-s2.0-S231941702300094X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10518907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for peri-intubation cardiac arrest: A systematic review and meta-analysis 插管周围心脏骤停的风险因素:系统回顾和荟萃分析
IF 5.5 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100656
Ting-Hao Yang , Shih-Chieh Shao , Yi-Chih Lee , Chien-Han Hsiao , Chieh-Ching Yen
{"title":"Risk factors for peri-intubation cardiac arrest: A systematic review and meta-analysis","authors":"Ting-Hao Yang ,&nbsp;Shih-Chieh Shao ,&nbsp;Yi-Chih Lee ,&nbsp;Chien-Han Hsiao ,&nbsp;Chieh-Ching Yen","doi":"10.1016/j.bj.2023.100656","DOIUrl":"10.1016/j.bj.2023.100656","url":null,"abstract":"<div><h3>Background</h3><p>Peri-intubation cardiac arrest (PICA) is an uncommon yet serious complication of intubation. Although some associated risk factors have been identified, the results have been inconsistent. The aim of this study was to systematically review the relevant research and examine the associated risk factors of PICA through meta-analysis.</p></div><div><h3>Methods</h3><p>Studies examining the risk factors for PICA before 1 Nov. 2022 were identified through searches in MEDLINE (OvidSP) and EMBASE. The reported adjusted or unadjusted odds ratios (ORs) and risk ratios (RRs) were recorded. We calculated pooled ORs and created forest plots using a random-effects model to identify the statistically significant risk factors. We assessed the certainty of evidence for each risk factor.</p></div><div><h3>Results</h3><p>Eight studies were included in the meta-analysis. Pre-intubation hypotension, with a pooled OR of 4.96 (95% confidence interval [C.I.]: 3.75–6.57), pre-intubation hypoxemia, with a pooled OR of 4.43 (95% C.I.: 1.24–15.81), and two or more intubation attempts, with a pooled OR of 1.88 (95% C.I.: 1.09–3.23) were associated with a significantly higher risk of PICA. The pooled incidence of PICA was 2.1% (95% C.I.: 1.5%–3.0%).</p></div><div><h3>Conclusions</h3><p>Pre-intubation hypotension, hypoxemia, and more intubation attempts are significant risk factors for PICA. The findings could help physicians identify patients at risk under the acute setting.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100656"},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000938/pdfft?md5=cfa3fb8a3cf723e56b2f7c3f6430764e&pid=1-s2.0-S2319417023000938-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10145499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study 根据美国指南修改的风险分层模型可用于患有或不患有 ASCVD 的亚洲人群:验证研究。
IF 5.5 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100653
Yu-Chung Hsiao , Thung-Lip Lee , Fang-Ju Lin , Chin-Feng Hsuan , Chih-Fan Yeh , Wei-Tien Chang , Hsien-Li Kao , Jiann-Shing Jeng , Yen-Wen Wu , I-Chang Hsieh , Ching-Chang Fang , Kuo-Yang Wang , Kuan-Cheng Chang , Tsung-Hsien Lin , Wayne Huey-Herng Sheu , Yi-Heng Li , Wei-Hsian Yin , Hung-I Yeh , Jaw-Wen Chen , Chau-Chung Wu
{"title":"A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study","authors":"Yu-Chung Hsiao ,&nbsp;Thung-Lip Lee ,&nbsp;Fang-Ju Lin ,&nbsp;Chin-Feng Hsuan ,&nbsp;Chih-Fan Yeh ,&nbsp;Wei-Tien Chang ,&nbsp;Hsien-Li Kao ,&nbsp;Jiann-Shing Jeng ,&nbsp;Yen-Wen Wu ,&nbsp;I-Chang Hsieh ,&nbsp;Ching-Chang Fang ,&nbsp;Kuo-Yang Wang ,&nbsp;Kuan-Cheng Chang ,&nbsp;Tsung-Hsien Lin ,&nbsp;Wayne Huey-Herng Sheu ,&nbsp;Yi-Heng Li ,&nbsp;Wei-Hsian Yin ,&nbsp;Hung-I Yeh ,&nbsp;Jaw-Wen Chen ,&nbsp;Chau-Chung Wu","doi":"10.1016/j.bj.2023.100653","DOIUrl":"10.1016/j.bj.2023.100653","url":null,"abstract":"<div><h3>Background</h3><p>This study aimed to evaluate the performance of a modified U.S. (MUS) model for risk prediction of cardiovascular (CV) events in Asian patients and compare it to European and Japanese models.</p></div><div><h3>Methods</h3><p>The MUS model, based on the US ACC/AHA 2018 lipid treatment guideline, was employed to stratify patients under primary or secondary prevention. Two multi-center prospective observational registry cohorts, T-SPARCLE and T-PPARCLE, were used to validate the scoring system, and the primary outcome was the time to first occurrence/recurrence of major adverse cardiac events (MACEs). The MUS model's performance was compared to other models from Europe and Japan.</p></div><div><h3>Results</h3><p>A total of 10,733 patients with the mean age of 64.2 (SD: 11.9) and 36.5% female were followed up for a median of 5.4 years. The MUS model was validated, with an AUC score of 0.73 (95% CI 0.68–0.78). The European and Japanese models had AUC scores ranging from 0.6 to 0.7. The MUS model categorized patients into four distinct CV risk groups, with hazard ratios (HRs) as follows: very high- vs. high-risk group (HR = 1.91, 95% CI 1.53–2.39), high- vs. moderate-risk group (HR = 2.08, 95% CI 1.60–2.69), and moderate- vs. low-risk group (HR = 3.14, 95% CI 1.63–6.03). After adjusting for the MUS model, a history of atherosclerotic vascular disease (ASCVD) was not a significant predictor of adverse cardiovascular outcomes within each risk group.</p></div><div><h3>Conclusion</h3><p>The MUS model is an effective tool for risk stratification in Asian patients with and without ASCVD, accurately predicting MACEs and performing comparably or better than other established risk models. Our findings suggest that patient management should focus on background risk factors instead of solely on primary or secondary prevention.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100653"},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000902/pdfft?md5=6e47c31c0ef3fb72396469975665e92e&pid=1-s2.0-S2319417023000902-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10000569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
And those who were seen dancing: Human interactions with fungi and vice versa 还有那些被看到跳舞的人:人类与真菌的互动,反之亦然。
IF 4.1 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2024.100755
Aila Akosua Kattner
{"title":"And those who were seen dancing: Human interactions with fungi and vice versa","authors":"Aila Akosua Kattner","doi":"10.1016/j.bj.2024.100755","DOIUrl":"10.1016/j.bj.2024.100755","url":null,"abstract":"<div><p>This issue of the Biomedical Journal features a special section exploring mycobiota. Three articles examine the role of fungi in common metabolic disorders in, <em>Clostridium difficile</em> infection, and in immunocompromised patients. Additionally, the potential and challenges of the metaverse in healthcare are reviewed, alongside a holistic approach to improve patient outcomes in pancreatic cancer. In this issue also possible mechanism contributing to long COVID are discussed, as well as biomarkers that effectively predict sepsis outcomes, and key targets in osteosarcoma progression. Moreover, factors leading to peri-intubation cardiac arrest are analyzed, healthcare strategies from various regions are employed to predict cardiovascular events in Asian populations, two approaches to cavernous sinus dural arteriovenous fistula are compared, and a combination therapy against soft tissue sarcoma is presented.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100755"},"PeriodicalIF":4.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417024000581/pdfft?md5=ecf4adc910ccd70d8ca8af07fd7ce50b&pid=1-s2.0-S2319417024000581-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using time-course as an essential factor to accurately predict sepsis-associated mortality among patients with suspected sepsis 将时间进程作为准确预测疑似败血症患者败血症相关死亡率的重要因素。
IF 4.1 3区 医学
Biomedical Journal Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100632
{"title":"Using time-course as an essential factor to accurately predict sepsis-associated mortality among patients with suspected sepsis","authors":"","doi":"10.1016/j.bj.2023.100632","DOIUrl":"10.1016/j.bj.2023.100632","url":null,"abstract":"<div><h3>Background</h3><p>Biomarker dynamics in different time-courses might be the primary reason why a static measurement of a single biomarker cannot accurately predict sepsis outcomes. Therefore, we conducted this prospective hospital-based cohort study to simultaneously evaluate the performance of several conventional and novel biomarkers of sepsis in predicting sepsis-associated mortality on different days of illness among patients with suspected sepsis.</p></div><div><h3>Methods</h3><p>We evaluated the performance of 15 novel biomarkers including angiopoietin-2, pentraxin 3, sTREM-1, ICAM-1, VCAM-1, sCD14 and 163, E-selectin, P-selectin, TNF-alpha, interferon-gamma, CD64, IL-6, 8, and 10, along with few conventional markers for predicting sepsis-associated mortality. Patients were grouped into quartiles according to the number of days since symptom onset. Receiver operating characteristic curve (ROC) analysis was used to evaluate the biomarker performance.</p></div><div><h3>Results</h3><p>From 2014 to 2017, 1483 patients were enrolled, of which 78% fulfilled the systemic inflammatory response syndrome criteria, 62% fulfilled the sepsis-3 criteria, 32% had septic shock, and 3.3% developed sepsis-associated mortality. IL-6, pentraxin 3, sCD163, and the blood gas profile demonstrated better performance in the early days of illness, both before and after adjusting for potential confounders (adjusted area under ROC curve [AUROC]:0.81–0.88). Notably, the Sequential Organ Failure Assessment (SOFA) score was relatively consistent throughout the course of illness (adjusted AUROC:0.70–0.91).</p></div><div><h3>Conclusion</h3><p>IL-6, pentraxin 3, sCD163, and the blood gas profile showed excellent predictive accuracy in the early days of illness. The SOFA score was consistently predictive of sepsis-associated mortality throughout the course of illness, with an acceptable performance.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 3","pages":"Article 100632"},"PeriodicalIF":4.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000690/pdfft?md5=8c7ed27e8824475c4fc37be363f94c91&pid=1-s2.0-S2319417023000690-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10214096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信